MedTrace Logo

Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China

NCT06717178 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 322

Last updated 2025-04-02

No results posted yet for this study

Summary

The goal of this observational study is to learn about the impact of chemotherapy-related toxicity on older cancer patients in China. The main question it aims to answer is:

Does the Cancer and Aging Research Group (CARG) chemotherapy toxicity risk score predict chemotherapy-related toxicity in Chinese cancer patients over age 70? Participants over age 70 on systemic chemotherapy will answer questions listed in the CARG chemotherapy toxicity risk tool.

Conditions

  • Cancer
  • Cancer-related Problem/Condition

Interventions

DRUG

Chemotherapy

Admission to the hospital for a new chemotherapy regimen (initial or change)

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Lirong Yang, PharmD · Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine

  • Xiaoxia Qiu, MS · Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-24
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06717178 on ClinicalTrials.gov